Skip to content

Advertisement

Volume 18 Supplement 2

Sepsis 2014

  • Poster presentation
  • Open Access

Clinical audit system in implementing Surviving Sepsis Campaign guidelines in patients with peritonitis

  • RC Valiveru1,
  • NK Maroju1,
  • K Srinivasan1 and
  • A Cherian2
Critical Care201418(Suppl 2):P30

https://doi.org/10.1186/cc14033

Published: 3 December 2014

Keywords

PeritonitisAudit SystemProspective Observational StudyProcess ImprovementSerum Lactate

Introduction

Sepsis is the predominant cause of morbidity and mortality in patients with peritonitis [16]. The Surviving Sepsis Campaign (SSC) is an international effort in reducing mortality based on evidence-based guidelines [713]. This study aims to assess the impact of audit-based feedback in a Plan-Do-Study-Act (PDSA) format on improving implementation of the SSC guidelines in patients with generalised peritonitis at our centre.

Methods

This prospective observational study was conducted in four audit cycles in PDSA format. Multidepartmental inputs were taken to suggest modifications in practice. A questionnaire-based analysis of reasons for noncompliance was done to find out the opinions and reasons for noncompliance. Morbidity, mortality, the ICU and hospital stay among these patients were also analysed.

Results

The baseline compliance with i.v. bolus administration, CVP-guided fluids and inotrope supports when indicated were 100%. Over the course of the three audit cycles, statistically significant improvement in compliance was noted for antibiotic administration within 3 hours of presentation (46% to 90%) (Table 1 Figure 1), obtaining blood cultures before antibiotics (13.8% to 72.5%) (Table 1 Figure 2) and serum lactate measurement (0% to 78.2%) (Figure 3). Overall bundle compliance improved from 9.2% to 64.7% (Table 2 Figure 4) by the end of Audit III. The mortality rate decreased from 32.3% to 20% (Table 2 Figure 5).
Table 1

Compliance with obtaining blood cultures before antibiotics and antibiotic administration within 3 hours.

Number of patients

Pre audit (n= 65)

Audit I (n= 55)

Audit II (n= 50)

Audit III (n= 51)

Blood cultures obtained before antibiotics

9 (13.6%)

18 (32.7%)a

30 (60%)b

37 (72.54%)b

Antibiotics given within 3 hours

30 (46.1%)

30 (67.2%)c

40 (80%)d

46 (90.1%)b

aP = 0.016. bP < 0.0001. cP = 0.463. dP = 0.0002.

Figure 1
Figure 1

Compliance with antibiotic administration within 3 hours of presentation.

Figure 2
Figure 2

Compliance with obtaining blood cultures before antibiotic administration.

Figure 3
Figure 3

Compliance with measurement of serum lactate.

Table 2

Total bundle compliance.

Total number of bundle components performed

Pre audit (n= 65)

Audit I (n= 55)

Audit II (n= 50)

Audit III (n= 51)

6

0

0

0

33a (64.7)

5

6 (9.2%)

13 (23.6%)

27 (54%)

3 (5.8%)

4

26 (40%)

29 (52.7%)

16 (32%)

11 (21.5%)

3

33 (50.7%)

13 (23.6%)

7 (14%)

4 (7.8%)

2

0

0

0

0

1

0

0

0

0

aSerum lactate was available in the hospital only during audit cycle III.

Figure 4
Figure 4

Overall bundle compliance.

Figure 5

Figure 5

Conclusion

This study demonstrates that audit-based feedback is a dependable means of improving compliance with SSC guidelines. It brings about improvement by educating users, by modifying their behaviour through feedback and also enhances process improvement by identifying and correcting systemic deficiencies in the organisation.
Table 3

Overall mortality.

 

Pre audit (n= 65)

Audit I (n= 55)

Audit II (n= 50)

Audit III (n= 51)

Overall mortality in percentage

21 (32.3%)

16 (29%)

12 (24%)

11 (20%)

P value (compared with the initial cycle)

 

0.843

0.407

0.143

Authors’ Affiliations

(1)
Department of Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India
(2)
Department of Anesthesiology and Critical Care, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India

References

  1. Afridi SP, Malik F, Ur-Rahman S, Shamim S, Samo KA: Spectrum of perforation peritonitis in Pakistan: 300 cases Eastern experience. World J Emerg Surg 2008, 3: 31. 10.1186/1749-7922-3-31View ArticlePubMedPubMed CentralGoogle Scholar
  2. Chakma SM, Singh RL, Parmekar MV, Singh KHG, Kapa B, Sharatchandra KH, Longkumer AT, Rudrappa S: Spectrum of perforation peritonitis. J Clin Diagn Res 2013, 7: 2518-2520.PubMedPubMed CentralGoogle Scholar
  3. Jimenez MF, Marshall JC: International Sepsis Forum: source control in the management of sepsis. Intensive Care Med 2001,27(Suppl 1):S49-S62.View ArticlePubMedGoogle Scholar
  4. Bali RS, Verma S, Agarwal PN, Singh R, Talwar N: Perforation peritonitis and the developing world. ISRN Surg 2014, 2014: 105492.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Søreide K, Thorsen K, Søreide JA: Strategies to improve the outcome of emergency surgery for perforated peptic ulcer. Br J Surg 2014, 101: e51-e64. 10.1002/bjs.9368View ArticlePubMedGoogle Scholar
  6. Noguiera C, Silva AS, Santos JN, Silva AG, Ferreira J, Matos E, Vilaça H: Perforated peptic ulcer: main factors of morbidity and mortality. World J Surg 2003, 27: 782-787. 10.1007/s00268-003-6645-0View ArticlePubMedGoogle Scholar
  7. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R, Surviving sepsis Campaign Guidelines Committee including The Pediatric Subgroup: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39: 165-228. 10.1007/s00134-012-2769-8View ArticlePubMedGoogle Scholar
  8. Marshall JC, Dellinger RP, Levy M: The Surviving Sepsis Campaign: a history and a perspective. Surg Infect 2010, 11: 275-281. 10.1089/sur.2010.024View ArticleGoogle Scholar
  9. Castellanos-Ortega A, Suberviola B, García-Astudillo LA, Holanda MS, Ortiz F, Llorca J, Delgado-Rodríguez M: Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med 2010, 38: 1036-1043. 10.1097/CCM.0b013e3181d455b6View ArticlePubMedGoogle Scholar
  10. Zambon M, Ceola M, Almeida-de-Castro R, Gullo A, Vincent JL: Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster. J Crit Care 2008, 23: 455-460. 10.1016/j.jcrc.2007.08.003View ArticlePubMedGoogle Scholar
  11. Kang MJ, Shin TG, Jo IJ, Jeon K, Suh GY, Sim MS, Lim SY, Song KJ, Jeong YK: Factors influencing compliance with early resuscitation bundle in the management of severe sepsis and septic shock. Shock 2012, 38: 474-479. 10.1097/SHK.0b013e31826eea2bView ArticlePubMedGoogle Scholar
  12. Wang Z, Xiong Y, Schorr C, Dellinger RP: Impact of sepsis bundle strategy on outcomes of patients suffering from severe sepsis and septic shock in china. J Emerg Med 2013, 44: 735-741. 10.1016/j.jemermed.2012.07.084View ArticlePubMedGoogle Scholar
  13. Li Z-Q, Xi X-M, Luo X, Li J, Jiang L: Implementing surviving sepsis campaign bundles in China: a prospective cohort study. Chin Med J (Engl) 2013, 126: 1819-1825.Google Scholar

Copyright

© Valiveru et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement